Daiwa Securities Group Inc. Omeros Corp Transaction History

Daiwa Securities Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$13.4 - $16.3 $1,313 - $1,597	98 Added 84.48%	214 $3,000
Q4 2020 Feb 04, 2021	SELL	$10.14 - $15.19 $1,957 - $2,931	-193 Reduced 62.46%	116 $2,000
Q2 2019 Jul 24, 2019	BUY	$15.0 - $19.62 $660 - $863	44 Added 16.6%	309 $5,000
Q1 2018 May 02, 2018	BUY	$9.0 - $20.16 $2,385 - $5,342	265 New	265 $3,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $747M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.